Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

HARP

Harpoon Therapeutics (HARP)

Harpoon Therapeutics Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:HARP
日付受信時刻ニュースソース見出しコード企業名
2024/03/1206 : 22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HARPHarpoon Therapeutics Inc
2024/03/1122 : 55Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:HARPHarpoon Therapeutics Inc
2024/03/1122 : 51Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:HARPHarpoon Therapeutics Inc
2024/03/1122 : 49Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:HARPHarpoon Therapeutics Inc
2024/03/1122 : 46Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:HARPHarpoon Therapeutics Inc
2024/03/1122 : 44Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:HARPHarpoon Therapeutics Inc
2024/03/1122 : 42Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:HARPHarpoon Therapeutics Inc
2024/03/1122 : 40Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:HARPHarpoon Therapeutics Inc
2024/03/1122 : 37Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:HARPHarpoon Therapeutics Inc
2024/03/1122 : 36Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:HARPHarpoon Therapeutics Inc
2024/03/1122 : 32Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:HARPHarpoon Therapeutics Inc
2024/03/1121 : 47Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HARPHarpoon Therapeutics Inc
2024/03/0906 : 04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HARPHarpoon Therapeutics Inc
2024/02/2821 : 37Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:HARPHarpoon Therapeutics Inc
2024/02/2821 : 34Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HARPHarpoon Therapeutics Inc
2024/02/2222 : 32Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:HARPHarpoon Therapeutics Inc
2024/02/2222 : 31Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HARPHarpoon Therapeutics Inc
2024/02/0821 : 00Edgar (US Regulatory)Form DEFM14A - Definitive proxy statement relating to merger or acquisitionNASDAQ:HARPHarpoon Therapeutics Inc
2024/02/0706 : 15Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:HARPHarpoon Therapeutics Inc
2024/01/3006 : 52Edgar (US Regulatory)Form PREM14A - Preliminary proxy statements relating to merger or acquisitionNASDAQ:HARPHarpoon Therapeutics Inc
2024/01/3006 : 28Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HARPHarpoon Therapeutics Inc
2024/01/1105 : 07PR Newswire (US)Kuehn Law Encourages AMAM, HARP, AXNX, and CPE Investors to Contact Law FirmNASDAQ:HARPHarpoon Therapeutics Inc
2024/01/0920 : 12IH Market NewsWall Street Highlights: HPE and Juniper Networks in Negotiations, Elliott Invests $1 Billion in Match Group, and MoreNASDAQ:HARPHarpoon Therapeutics Inc
2024/01/0907 : 20Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:HARPHarpoon Therapeutics Inc
2024/01/0907 : 16Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:HARPHarpoon Therapeutics Inc
2024/01/0822 : 04Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:HARPHarpoon Therapeutics Inc
2024/01/0822 : 01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HARPHarpoon Therapeutics Inc
2024/01/0821 : 30Business WireMerck to Acquire Harpoon Therapeutics, Further Diversifying Oncology PipelineNASDAQ:HARPHarpoon Therapeutics Inc
2024/01/0607 : 04Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:HARPHarpoon Therapeutics Inc
2023/12/2621 : 30GlobeNewswire Inc.Harpoon Therapeutics Strengthens Leadership TeamNASDAQ:HARPHarpoon Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:HARP

最近閲覧した銘柄

Delayed Upgrade Clock